US Patent 11160771 Enhanced delivery epinephrine compositions
Patent 11160771 was granted and assigned to Aquestive Therapeutics on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+112 characters)
Article
Patent abstract
Pharmaceutical compositions having enhanced active component permeation properties are described.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Alexander Mark Schobel0
Stephanie Marie Varjan0
Stephen Paul Wargacki0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111607710
Date of Patent
November 2, 2021
0Patent Application Number
201705040
Date Filed
May 4, 2017
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11160771 Enhanced delivery epinephrine compositions
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11160771
Date of patent
November 2, 2021
Patent application number
20170504
Date Filed
May 4, 2017
Find more entities like US Patent 11160771 Enhanced delivery epinephrine compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.